PHIBRO ANIMAL HEALTH CORP (PAHC)

↓ Download CSV

CIK 0001069899 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

In fiscal 2026, PHIBRO ANIMAL HEALTH CORP reported revenue of $1.52B, up 17.1% from the prior year. The company was profitable, with a net margin of 6.6% and a gross margin of 33.8%. It held $1.50B in total assets against $1.12B in total liabilities.

Key ratios (FY2026)

33.8%
Gross margin
12.8%
Operating margin
6.6%
Net margin
25.9%
Return on equity
+17.1%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$1.52B$1.30B$1.02B$977.89M$942.26M$833.35M$800.35M
Cost of Revenue$1.01B$896.27M$704.59M$679.65M$656.86M$561.97M$543.47M$563.37M$553.10M$516.04M
Gross Profit$512.51M$399.94M$313.09M$298.24M$285.40M$271.38M$256.88M$264.62M$266.88M$248.24M
Operating Income$194.40M$110.47M$53.31M$71.85M$78.99M$74.87M$69.19M$83.23M$98.93M$97.93M
Net Income$99.72M$48.26M$2.42M$32.61M$49.17M$54.38M$33.55M$54.71M$64.88M$64.61M
EPS (Diluted)$2.43$1.19$0.06$0.81$1.21$1.34$0.83$1.35$1.61$1.61
Total Assets$1.50B$1.36B$982.18M$971.40M$931.70M$841.33M$784.10M$726.67M$671.68M$623.40M
Total Liabilities$1.12B$1.08B$725.54M$688.89M$669.26M$602.80M$595.90M$510.66M$486.73M$472.24M
Shareholders' Equity$385.48M$285.68M$256.64M$282.51M$262.44M$238.53M$188.20M$216.01M$184.95M$151.16M
Cash & Equivalents$61.42M$68.04M$70.61M$41.28M$74.25M$50.21M$36.34M$57.57M$29.17M$56.08M
Operating Cash Flow$68.95M$80.12M$87.59M$13.31M$31.65M$48.31M$59.35M$47.17M$70.01M$98.39M
Capital Expenditures$59.09M$38.29M$41.24M$51.79M$37.04M$29.32M$34.05M$29.89M$18.55M$20.88M
Shares Outstanding40.96M40.68M40.52M40.50M40.50M40.50M40.50M40.5K40.4K40.0K
Dividends Per Share$0.48$0.48$0.48$0.48$0.48$0.48$0.48$0.46$0.40$0.40